Archive for the ‘research’ Category

Lyme Disease Vaccine For Humans: Would You Trust It?

https://danielcameronmd.com/lyme-disease-vaccine-for-humans-would-you-trust-it/

LYME DISEASE VACCINE FOR HUMANS: WOULD YOU TRUST IT?

Lyme disease vaccine for humans being given to male patient

It has been 18 years since GlaxoSmithKlein pulled its preventative Lyme disease vaccine for humans, known as LYMErix, from the market. Now, a new vaccine is currently in Stage 2 clinical trials. This vaccine is also derived, in part, from the same OspA bacterial protein found in LYMErix. This begs the question: Will a new Lyme disease vaccine succeed or suffer the same fate as LYMErix?


LYMErix was reportedly effective at preventing a Lyme disease rash. But the vaccine was only 50% effective at preventing other manifestations of Lyme disease, according to the LYMErix package insert. LYMErix was voluntarily removed from the market due to low demand.

In a survey of 1,015 adults in the U.S., author Matt Motta¹ addresses the question of whether growing concern over climate change and the spread of tick-borne illnesses could increase public acceptance and use of a new Lyme disease vaccine for humans.

Survey respondents were asked, “how likely they are to request to be vaccinated when a Lyme vaccine becomes available for public use?”

The results indicated that “climate change concern is positively and significantly (B = 1.36, p < 0.01) associated with increased vaccination intentions,” the author writes.

Not surprisingly, survey findings showed, “Individuals who live in the Northeast, where Lyme is most prevalent, are more likely to intend to vaccinate (B = 1.35, p < 0.01), while people who place less trust in scientific authorities like the CDC are less likely to do so (B = À1.81, p < 0.01).”

Survey results, however, don’t guarantee the new Lyme disease vaccine for humans will be embraced by the public, writes Mott.

He describes several reasons why LYMErix was removed from the market:

“Low demand for LYMErix may have arisen from several factors, including its cost and the fact that it must be administered in two or three doses to reach high levels of effectiveness.”

“Misinformation about the vaccine’s safety – including the scientifically disputed claim that it can have adverse autoimmune effects – have also been linked to the vaccine being discontinued.”

References:
  1. Motta M. Could concern about climate change increase demand for a Lyme disease vaccine in the U.S.? Vaccine. 2020.

______________________

**Comment**

Another great example of important research tagged with the unimportant moniker ‘climate change’ regarding the spread of ticks and the diseases they transmit.  For the millionth time:  https://madisonarealymesupportgroup.com/2018/11/07/ticks-on-the-move-due-to-migrating-birds-and-photoperiod-not-climate-change/

According to tick researcher John Scott, TICKS ARE IMPERVIOUS TO WEATHER.

Please spread the word and don’t be duped by another money grab.

Please note the continuing emphasis on clearance of the rash, which does NOT equate to clearance of a systemic infection, so while the vaccine appears to clear the rash, (which it often does of its own accord anyway) it is only 50% effective against other manifestations of Lyme disease.  My guess is they also did not study these patients for long enough to determine if they developed other manifestations.

Regarding Lymerix:   https://madisonarealymesupportgroup.com/2018/01/28/the-secret-x-files-the-untold-history-of-the-lymerix-vaccine/

Excerpt:

Quotes from the patients affected by the LYMErix VACCINE:

“…..Smithkline should not be able to destroy people’s lives as they have destroyed mine …”

“… As of May 8, 2000 there were 467 adverse reactions reported to VAERS, and of them 144 had complained of some sort of joint pain. Please do not let this vaccine hurt anymore people. I know SmithKline is trying to get it approved for children, PLEASE DO NOT LET THEM HURT ANYMORE KIDS…”

“….. The FDA let them put this on the market without fully testing it. The longer that this is left on the market, the more people are going to get hurt. Please stop this madness and take it off the market…”

“….. No one else should ever suffer such profound life changes through the administration of a “safe” vaccine. He would have been far better off to get Lyme Disease than to be incapacitated by something we counted on to protect his health!…”

“….Please stop this vaccine from wrecking more lives! !Respectfully submitted…”

Dr. Lapenta also lists 13 patient stories of adverse reactions due to Lymerix that will curl your hair.

Further, this astute article reveals OZ behind the curtain.  A shady meeting at Dearborn, Michigan changed Lyme testing criteria so they could make their lucrative, adverse reaction riddled vaccine. Due to this, the sickest patients no longer meet the standard:   https://madisonarealymesupportgroup.com/2020/02/10/the-bitter-feud-over-lymerix/

So in answer to Dr. Cameron’s question: “Would you trust a Lyme vaccine?”, the answer isn’t just a “No,” it’s a “Hell No”. 

I’m with Weiler:  https://madisonarealymesupportgroup.com/2020/09/01/it-is-time-to-reboot-public-health-time-for-a-cdc-niaid-fda-walk-away-movement/

For more:  https://madisonarealymesupportgroup.com/2019/10/19/no-lyme-vaccine-until-persistent-infection-is-acknowledged-and-fully-addressed-period/

https://madisonarealymesupportgroup.com/2018/07/22/why-we-care-so-strongly-about-a-potential-lyme-vaccine/

https://madisonarealymesupportgroup.com/2018/07/01/lyme-vaccine-fail-safety-ignored/

https://madisonarealymesupportgroup.com/2020/08/12/what-is-life-like-for-the-vaccine-injured/

The issue regarding vaccines is quite similar to an issue surrounding COVID-19.  Unfortunately due to fear, many put so much emphasis on ONE issue they remain blind to 1,000 others.  For example, vaccines have injured, maimed and actually killed people.  Should fear of disease outweigh these people and their negative outcomes, which includes death, in the annuls of history?  Regarding COVID-19, should fear of a virus negate the suffering of people with other issues that are not COVID-19? 

We are being told daily that vaccines and COVID-19 trump all other issues.  I flat-out disagree.

This lie is a form of bullying.

Vaccination – What’s Trust Got to Do With It?

http://

NVIC co-founder and president Barbara Loe Fisher discusses questions the public is asking about infectious disease and vaccines and changes in public perceptions during the 2020 debate about vaccine science, policy and law. 

If you would rather read the commentary:  https://www.nvic.org/NVIC-Vaccine-News/September-2020/vaccination-whats-trust-got-to-do-with-it.aspx

 

 

 

 

 

New Study: The Hidden Ways Microbes Control Tick Behavior

https://rawlsmd.com/health-articles/new-study-the-hidden-ways-microbes-control-tick-behavior?

New Study: The Hidden Ways Microbes Control Tick Behavior

New Study: The Hidden Ways Microbes Control Tick Behavior

by Jenny Lelwica Buttaccio
Posted 9/17/20

We’ve heard a lot of late about an increase in Lyme disease cases, but tick-borne diseases of all kinds — including babesiosis, anaplasmosis, rickettsiosis, and others — are on the rise throughout the United States, reports the Centers for Disease Control and Prevention (CDC). At least part of the increase in tick-borne illnesses can be traced to an expanding tick population, caused by several factors including changes in climate patterns and the development of housing into wooded areas, creating closer interactions between people, animals, and ticks.

But what if there’s also an unseen force at work compelling ticks to act out or present with certain behaviors that give them a leg up when it comes to their own survival — and that of the microbes they carry? New research suggests that perhaps there’s more to this story than we know.

First, a Basic Overview of Ticks On the Hunt

More than four decades after the first cases of Lyme disease were diagnosed, we’re still learning about tick behavior and why they operate in the way they do. We know that blood hosts like humans and animals are critical for tick survival, so ticks are regularly on the prowl.

A tick’s vision isn’t very good, so they rely on other sensory components to find food sources. Located on the first pairs of ticks’ legs are tiny structures called Haller’s organs. These organs are found only on ticks, and it is believed that they function somewhat like antennae and utilize the sense of smell to detect odors wafting through the air to find unsuspecting hosts.

Using their Haller’s organs, ticks detect the carbon dioxide (CO2) that comes from human respiration and breathing — they can sense other chemicals like ammonia and pheromones, too. While certain ticks, like the Lone Star tick, can aggressively charge potential human hosts, most prefer a more subtle approach: Waiting patiently on blades of grass or areas of brush until you approach them, an activity known as “questing.”

diagram of tick biology

When a tick quests, they grip the blade of grass or brush with their back legs and stretch their front legs into the air. In due time, a human or animal walks past, and they latch on, using the front legs to ascend their new host and search for a suitable spot to begin feeding.

As weird and as sci-fi as all this sounds, emerging research from Giovanni Benelli, PhD, Senior Research Entomologist at the University of Pisa in Pisa, Italy, has begun to shed light on microscopic agents that exert influence upon ticks’ hunting behavior. Interestingly, it’s the very microbes we work so hard to avoid that play puppeteer to their tick hosts.

6 Microbes that Manipulate Tick Behavior

In August 2020, Benelli published a new review in the journal Pathogens investigating whether microbes Anaplasma, Borrelia, Babesia, Bartonella, Rickettsia, and tick-borne encephalitis virus (TBEV) were involved in influencing tick behavior and adaptive significance (traits that affect a tick’s reproductive success). Pathogenic manipulation — such as an increase in biting frequency and duration and changing host-borne odors to make them more appealing meals for other arthropods like mosquitos and sand flies — has already been noted in scientific literature.

In regards to ticks, Bellini’s data suggests modes of pathogen-tick manipulation may include physiological changes, tolerance to extreme temperatures, and enhanced survivability, among others. Here, we’ll take a look at some of the key highlights of Benelli’s research, a wealth of further insights into tick behavior that could be a crucial factor in helping to curtail the bugs’ proliferation and their ability to spread chronic illnesses.

1. How Borrelia Impacts Tick Behavior

Borrelia is the bacteria implicated in Lyme disease. In the United States, Borrelia burgdorferi is the species that’s found in black-legged ticks (Ixodes scapularis) or deer ticks. However, in Europe, the predominant Lyme disease-carrying tick is the castor bean tick (Ixodes ricinus).

Borrelia infection in the blood. Borrelia bacteria cause borreliose, transmitted by ticks and by lice.

Borrelia may manipulate tick behavior in both tick species, according to Bellini’s review. Here are some of his key findings:

Key Findings:

  • Black-legged nymph ticks infected with B. burgdorferi showed enhanced movement toward or away from light sources (phototaxis).
  • Nymph ticks infected with B. burgdorferi demonstrated an affinity for vertical surfaces such as the top layers of leaf litter piles or plant vegetation like blades of grass, which may provide them with more opportunities to come into contact with hosts.
  • B. burgdorferi stimulated tick histamine release factor (tHRF), the chemical that regulates vascular permeability and improves blood flow to the site of the bite for feeding.
  • Infected adult black-legged ticks had slower mobility than their non-infected counterparts. However, research is unclear whether this is a behavior adaptation resulting from B. burgdorferi.
  • Castor bean nymph ticks exposed to extremely dry conditions showed they were more active and more resistant to harsh conditions than those that were not carrying the pathogen.
  • Nymph ticks carrying a strain of Borrelia known as Borrelia afzelii (a European strain known for its ability to affect the central nervous system) had increased rates of mobility, including duration and speed of movement, over non-infected ones.

The Takeaway

Indeed B. burgdorferi may manipulate tick behavior in several ways, but Bellini acknowledges that further research is needed to determine how these behaviors contribute to disease and how the data can be used to slow the spread of ticks and prevent the transmission of Lyme disease.

2. How Anaplasma Affects Tick Behavior

All ticks, including the black-legged tick, carry multiple disease-causing microbes known as coinfections. One such microbe is Anaplasma phagocytophilum, previously called human granulocytic ehrlichiosis (HGE). When a tick is infected with A. phagocytophilum, it may demonstrate behavioral changes that influence survival, questing, and feeding.

Anaplasma microbe, microscope view

The following three are important points to note from Bellini’s research:

Key Findings

  • A. phagocytophilum-infected black-legged ticks create heat shock proteins in response to stressful environmental circumstances. This makes them more resilient to extremely dry environments and boosts their survivability rates.
  • In the non-infected tick population, cold temperatures can raise the tick mortality rate. But ticks that have been infected with A. phagocytophilum have an advantage — they manufacture an antifreeze glycoprotein that guards them against the cold.
  • A. phagocytophilum is present in the salivary glands of ticks, and it inhibits cellular death to allow for the infection to be transmitted from the tick’s vector to the host, fostering more effective feeding and greater survival.

The Takeaway

The relationship between A. phagocytophilum and tick manipulation is a better-researched interaction than that of other ticks and pathogens. The mechanisms by which A. phagocytophilum alters the behavior of the tick are more apparent in terms of how it augments tick reproduction and survivability. However, when it comes to other species of Anaplasma that may impact humans or animals, more research is needed.

3. How Babesia Affects Tick Behavior

Babesia is a distant cousin of malaria and a less virulent microbe, comparatively. Babesia may occur in up to 40% of people infected with Lyme disease, indicates a report in Trends in Parasitology, making it a relatively common coinfection. The species of Babesia that are most likely to pose a disease risk to humans are Babesia microti, Babesia divergins, and Babesia ducani (WA-1).

Babesia microbe, zoomed view, round

Regarding Benelli’s review, only a few studies have looked at the effects Babesia may have on tick behavior, but he noted the following:

Key Findings

  • B. microti maximized the success of feeding and strengthened the survival of shrew ticks (Ixodes trianguliceps), but these modifications didn’t correlate with the strain’s infection rates.
  • In animal studies, B microti delayed the amount of time it took for a tick to become engorged.
  • Nymph ticks that fed on infected hosts had a higher body weight than those that fed on non-infected ones.
  • Larvae who fed on infected hosts shed their skin more quickly (a process known as molting) than those that fed on non-infected ones.

The Takeaway

At present, the research on Babesia species and their ability to manipulate tick behavior is scant. The processes that encourage feeding, development, and the survival of ticks infected with Babesia have yet to be determined.

4 & 5. How Bartonella and Rickettsia Affect Tick Behavior

Rickettsia microbe, zoomed in microscope view

Although Bartonella, a common coinfection found in people with Lyme, and Rickettsia, a highly virulent and life-threatening microbe, can pose serious health risks to humans, little is known about the behavioral changes these infections may have on tick behavior. A few points worthy of consideration include:

Key Findings

  • Bartonella-infected castor bean ticks had an increase in a component called Ixodes ricinusserine protease inhibitor (IrSPI). This enzyme inhibitor is involved in such biological processes as inflammation, blood clotting, wound healing, constricting blood vessels, and altering hosts’ defense systems.
  • Rickettsia-infected ticks demonstrated a greater inclination towards electromagnetic fields than non-infected ones.

The Takeaway

Like Babesia, the research on Bartonella- and Rickettsia-infected ticks is minimal. However, because annual incidences are on the rise, continued investigation in this area has the potential to bring about crucial information for the benefit of public health.

6. How Tick-Borne Encephalitis Virus Affects Tick Behavior

Tick-borne encephalitis (TBEV) is a viral infection spread through the bite of an infected tick. The virus resides throughout Europe and Asia, according to the CDC, making the infection relatively unknown in the U.S.

Encephalitis microbe, zoomed in microscope view

Between 20% and 30% of people who acquire the infection develop symptoms that affect the nervous system. Evidence for two hypotheses suggest the virus can manipulate tick behavior in the following ways:

Key Findings

  • TBEV intensifies tick movement and the ability to find a host.
    Feeding results in higher concentrations of TBEV.
  • When a TBEV-infected tick is unfed, the concentration of the virus remains low. But when the tick feeds, the TBEV titers raise to reach detectable levels.
  • A percentage (6%) of TBEV-infected adult castor bean ticks can navigate DEET-covered areas with a 1% formulation. In contrast, uninfected ticks were unable to cross these areas.

Takeaway

In general, ticks infected with TBEV demonstrated enhanced tick mobility, including walking speed and duration, and a proclivity toward higher questing heights. These changes may lead to greater outcomes when it comes to tick and microbe survivability.

Putting It All Together

There’s no doubt that’s an incredible amount of information to take it in. But this valuable data sets the stage for the urgent need for ongoing research when it comes to understanding how pathogens affect and modify tick behavior.

There is a wide array of tick species worldwide, and countless disease-causing pathogens that pose a threat to human health. Tracking behavioral changes in infected and non-infected ticks could one day lead to positive, new developments for halting the spread of tick-borne diseases.

In the meantime, your best bet is to practice good tick-prevention strategies like doing regular tick checks when coming in from the outdoors, wearing permethrin-treating shoes and clothing, and promptly removing attached ticks with a pair of fine-pointed tweezers. 

REFERENCES

1. Alberdi P, Espinosa PJ, Cabezas-Cruz A, de la Fuente J. Anaplasma phagocytophilum Manipulates Host Cell Apoptosis by Different Mechanisms to Establish Infection. Vet Sci. 2016;3(3):15. Published 2016 Jul 15. doi: 10.3390/vetsci3030015
2. Benelli G. Pathogens Manipulating Tick Behavior-Through a Glass, Darkly. Pathogens. 2020;9(8):E664. Published 2020 Aug 17. doi: 10.3390/pathogens9080664
3. Blisnick AA, Šimo L, Grillon C, et al. The Immunomodulatory Effect of IrSPI, a Tick Salivary Gland Serine Protease Inhibitor Involved in Ixodes ricinus Tick Feeding. Vaccines (Basel). 2019;7(4):148. Published 2019 Oct 12. doi: 10.3390/vaccines7040148
4. Carr AL, Mitchell RD III, Dhammi A, Bissinger BW, Sonenshine DE, Roe RM. Tick Haller’s Organ, a New Paradigm for Arthropod Olfaction: How Ticks Differ from Insects. Int J Mol Sci. 2017;18(7):1563. Published 2017 Jul 18. doi: 10.3390/ijms18071563
5. Dai J, Narasimhan S, Zhang L, Liu L, Wang P, Fikrig E. Tick histamine release factor is critical for Ixodes scapularis engorgement and transmission of the lyme disease agent. PLoS Pathog. 2010;6(11):e1001205. Published 2010 Nov 24. doi: 10.1371/journal.ppat.1001205
6. Lyme and Other Tickborne Diseases Increasing. Centers for Disease Control and Prevention website. https://www.cdc.gov/media/dpk/diseases-and-conditions/lyme-disease/index.html#:~:text=The%20reported%20numbers%20of%20cases,59%2C349%20reported%20cases%20in%202017.
7. Tick-borne encephalitis. Centers for Disease Control and Prevention website. https://wwwnc.cdc.gov/travel/diseases/tickborne-encephalitis#:~:text=Tick%2Dborne%20encephalitis%20(TBE),headache%2C%20nausea%2C%20and%20vomiting
_____________________
 
**Comment**
 
This explains a lot – if only mainstream medicine/research will listen instead of conducting more climate data. It also makes sense.
 
 
It is commonly known that parasites affect behavior:

Parasites are a whole new fantastical frontier. I’ll never forget this information on how parasites affect human behavior by Dr. Klinghardt, which I found here:  http://www.betterhealthguy.com/a-deep-look-beyond-lyme

  • Parasite patients often express the psyche of the parasites – sticky, clingy, impossible to tolerate – but a wonderful human being is behind all of that.

  • We are all a composite of many personalities. Chronic infections outnumber our own cells by 10:1. We are 90% “other” and 10% “us”. Our consciousness is a composite of 90% microbes and 10% us.

  • Our thinking, feeling, creativity, and expression are 90% from the microbes within us. Patients often think, crave, and behave as if they are the parasite.

  • Our thinking is shaded by the microbes thinking through us. The food choices, behavioral choices, and who we like is the thinking of the microbes within us expressing themselves.

  • Patients will reject all treatments that affect the issue that requires treating.

  • Patients will not guide themselves to health when the microbes have taken over.

It only follows that parasites will affect tick behavior as well.

5th Annual LymeMind Virtual Conference – Oct. 10, 2020

https://www.lymemind.org  (Register Here & to View More Details)

5th Annual LymeMIND Virtual Conference 2020

We’re bringing together researchers, patients, sponsors, and other interested parties to share knowledge and experience related to Lyme disease research. To ensure the safety of all the attendees, we’ve decided to conduct this year’s conference in a virtual half-day program. We’ll be offering pre-recorded presentations and panel discussions. There will be a live Q&A after each segment.

  • Saturday, October 10
  • 9am-1pm
  • Virtual Event

Advancing Lyme disease research through an integrated network of researchers, patients, physicians, and sponsors.

Registration is open

AGENDA

9:00am10minVIRTUAL EVENT

Chairperson – Welcome & Opening Remarks

  • Patricia (Savi) Glowe
    Patricia (Savi) Glowe
9:10am30minVIRTUAL EVENT

KEYNOTE – “Chronic: The Hidden Cause of Autoimmune Pandemic and How to Get Healthy Again.”

  • Steven Phillips, MD
    Steven Phillips, MD
  • Dana Parish
    Dana Parish
9:40am30minVIRTUAL EVENT

Mothers and Children Panel Discussion – Phyllis Bedford – Moderator

  • Phyllis Bedford
    Phyllis Bedford
  • Holly Ahern, MT(ASCP)
    Holly Ahern, MT(ASCP)
  • Sue Faber, RN, BScN
    Sue Faber, RN, BScN
  • Charlotte, Mao, MD
    Charlotte, Mao, MD
10:10am15minVIRTUAL EVENT

COVID-19- in the context of Lyme disease

  • Jason Bobe, MSc
    Jason Bobe, MSc
  • Richard Horowitz, MD
    Richard Horowitz, MD
  •  David Putrino, PT, PhD
    David Putrino, PT, PhD
10:25am15minVIRTUAL EVENT

Insights from Data Mining of Lyme Disease Patients by LymeMIND

  • Avi Ma’ayan, PhD
    Avi Ma’ayan, PhD
10:40am40minVIRTUAL EVENT

Novel Treatments: Making sense of all the treatment options – Panel – John Aucott – Moderator

  • John Aucott, MD
    John Aucott, MD
  • Tania Tyles Dempsey, MD, ABIHM
    Tania Tyles Dempsey, MD, ABIHM
  • Andrew Petterson, DO
    Andrew Petterson, DO
  • Richard Horowitz, MD
    Richard Horowitz, MD
11:20am30minVIRTUAL EVENT

Bartonella and Co-infections

  • Marna Ericson, PhD
    Marna Ericson, PhD
  • Robert Mozayeni, MD
    Robert Mozayeni, MD
  • Monica Embers, PhD
    Monica Embers, PhD
  • Edward Breitschwerdt, DVM
    Edward Breitschwerdt, DVM
11:50am10minVIRTUAL EVENT

Lyme Disease – 5 years of progress

  • Jason Bobe, MSc
    Jason Bobe, MSc
12:00pm8minVIRTUAL EVENT

Call to Action: Center for Lyme Action

  • Bonnie L. Crater
    Bonnie L. Crater
12:08pm2 minsVIRTUAL EVENT

Lyme Biobank’s tissue repository

  • Liz Horn, PhD, MBIP
    Liz Horn, PhD, MBIP
12:10pm15minVIRTUAL EVENT

Looking towards the future

  • Bennett Nemser MPH, MBA
    Bennett Nemser MPH, MBA
  • John Aucott, MD
    John Aucott, MD
  • Brian A. Fallon, MD, MPH
    Brian A. Fallon, MD, MPH
12:25pm10 minsVIRTUAL EVENT

LymeX Innovation Accelerator

  • ADM Brett P. Giroir, MD
    ADM Brett P. Giroir, MD
  • Kristen Honey, PhD, PMP
    Kristen Honey, PhD, PMP
  • Eric D. Hargan, JD, BA
    Eric D. Hargan, JD, BA
12:35pm5 minsVIRTUAL EVENT

Savi Glowe – Closing Remarks

  • Patricia (Savi) Glowe
    Patricia (Savi) Glowe
ABOUT US

LymeMIND utilizes innovation, transparency and collaboration to accelerate the field of Lyme disease research.

Through our integrated knowledge base, we aim to help Lyme disease researchers identify novel biomarkers and therapeutic target candidates. LymeMIND brings together leaders in Lyme disease research through collaborations, educational events, and an annual conference.

LymeMIND is made possible by generous support from the Cohen Lyme & Tickborne Disease Initiative. Launched in 2015, the Initiative seeks to gather the brightest minds within the research and medical communities to better understand and ultimately stop the rapid spread of tickborne illnesses. It has committed over $60 million to more than 25 research projects across the nation.

Molecular Mechanism for Rotational Switching of the Bacterial Flagellar Motor

https://www.nature.com/articles/s41594-020-0497-2

Published:

Molecular mechanism for rotational switching of the bacterial flagellar motor

Abstract

The bacterial flagellar motor can rotate in counterclockwise (CCW) or clockwise (CW) senses, and transitions are controlled by the phosphorylated form of the response regulator CheY (CheY-P). To dissect the mechanism underlying flagellar rotational switching, we use Borrelia burgdorferias a model system to determine high-resolution in situ motor structures in cheXand cheY3 mutants, in which motors are locked in either CCW or CW rotation. The structures showed that CheY3-P interacts directly with a switch protein, FliM, inducing a major remodeling of another switch protein, FliG2, and altering its interaction with the torque generator. Our findings lead to a model in which the torque generator rotates in response to an inward flow of H+driven by the proton motive force, and conformational changes in FliG2 driven by CheY3-P allow the switch complex to interact with opposite sides of the rotating torque generator, facilitating rotational switching.

________________________

Global Lyme Alliance states the following about the study:  https://globallymealliance.org/news/yale-scientists-unlock-new-insight-into-the-lyme-disease-bacterium/

SCIENTISTS AT YALE HAVE UNLOCKED A 50-YEAR PUZZLE OF HOW THE LYME BACTERIUM SPREADS HARMFUL DISEASE.

Published this week in Nature Structural & Molecular Biology, scholars from the Yale Microbial Sciences Institute provide a major new insight to the corkscrew-shaped bacterium – or spirochete – that causes Lyme disease.

The Lyme disease bacterium, Borrelia burgdorferi, spreads through our bodies using a corkscrew-like motion.

For the first time, cryo-electron microscopes have given an up-close look at how the bacterial motors drive clockwise or counter-clockwise motion.

Spirochetes are like smart cars – burrowing into tissues, nerves and joints able to move forward and in reverse. So far scientists have been unable to dissect this mechanism at a molecular level, until now.

“We were able to reveal the direct interactions between a signaling protein and the switch proteins that control the rotational switching in the Lyme disease spirochete for the first time through the lens of a cryo-electron microscope (cryo-EM),” explained the study’s first author, Yunjie Chang, a postdoc in the lab of Jun Liu at Yale University’s West Campus.

The cryo-EM technique flash-freezes the cells to around -270°F then bombards them with electrons to produce thousands of 2D images, which are then combined together to reveal a 3D model, the structural basis to understand the rotational switching.

“This microscope is key,” said senior author Jun Liu, associate professor of Microbial Pathogenesis. “The power allows us to see through the Lyme disease vehicle, to understand how it navigates and disseminates in its hosts, and how in the future we can control it.”

This is important because now we can begin to understand how the bacteria spreads, with the possibility of new targets for treatment.

University of New Haven Professor Makes Great Strides in Lyme Disease, Cancer Research

https://www.newhaven.edu/news/blog/2020/eva-sapi-research.php

University of New Haven Professor Makes Great Strides in Lyme Disease, Cancer Research

An internationally recognized expert on Lyme disease, Eva Sapi, Ph.D., has made groundbreaking discoveries in the lab that have shed light on the bacteria that cause the disease, as well as a possible link between Lyme disease and another largely unknown and increasingly common illness: breast cancer.

SEPTEMBER 15, 2020

By Renee Chmiel, Office of Marketing and Communications

Dr. Eva Sapi with students.
Dr. Eva Sapi’s students have been an integral part of her research.

Eva Sapi, Ph.D., has long been on the front lines in the search for a cure for Lyme disease – a disease that she herself contracted several years ago.

Director of the University’s Lyme Disease Research Group, Dr. Sapi is an internationally recognized expert on the disease, which the Centers for Disease Control and Prevention say is the most common vector-borne disease in the United States. It is caused by the bacterium Borrelia burgdorferi, and it is typically spread by ticks.

Dr. Sapi has spoken with media across the country, including CNN, warning of a “perfect storm” this year for Lyme disease, given the COVID-19 pandemic and the mild winter that, she says, contributed to a “bad year for ticks.”

Eva and students at a research conference
Left to right: Min Zhang ’20 M.S., Gauri Gaur ’20 M.S., Eva Sapi, Ph.D., and Ankita Chavan ’22 M.S.

A trained breast cancer researcher, Dr. Sapi spent 15 years conducting breast and ovarian cancer research at Yale University before shifting her focus to Lyme disease. These two research areas may be linked more closely than previously thought, and she is currently exploring a possible link between breast cancer and Lyme disease.

“I’d heard about people who suffered from Lyme disease and then received a breast cancer diagnosis soon after,” said Dr. Sapi, coordinator of the University’s graduate program in cellular and molecular biology. “I wondered if the Borrelia bacteria were in breast cancer tissue. My research group examined slides with several kinds of breast cancer, as well as healthy tissues. The normal breast tissues were completely negative for the bacteria, and we have found evidence that they are present in breast cancer tissues. Furthermore, when we introduced Borrelia to cancer cells, we found they start to invade very quickly.”

‘Presenting at the conference was a great experience’

Although the etiology of breast cancer is still unknown, it is believed to be caused by a combination of genetic and environmental factors – one of which, Dr. Sapi believes, may be bacterial infection. She and her students, who have been an integral part of her research, are focusing on Borrelia. When examining more than 400 invasive breast cancer tissues, they found that a significant number of samples were positive for Borrelia, suggesting that the bacteria may play a role in breast cancer development and metastasis.

Eva Sapi and Sam Sorbello.
Eva Sapi and Sam Sorbello.

Dr. Sapi and several of her students – including Min Zhang ’20 M.S. and Gauri Gaur ’20 M.S. – presented their research examining a possible breast cancer/Lyme disease link and developing a novel model system for Borrelia at last year’s International Lyme and Associated Diseases Society conference.

Recent graduates of the University’s graduate program in cellular and molecular biology, Gaur and Zhang worked closely with Dr. Sapi as part of the Lyme Disease Research Group. Gaur was the leading graduate student in the breast cancer project, while Zhang developed a zebrafish model for the Lyme disease bacteria.

“The zebrafish model allows for rapid, non-invasive, and real-time analysis of Lyme disease bacteria,” she said. “This animal model shows the potential to extend our understanding of the interplay between bacterial virulence factors and host defense mechanisms in the pathogenesis of Borrelia. Presenting at the conference was a great experience, and it enabled me to get feedback from professional peers.”

‘I hope this research puts a different perspective on all cancer’

Dr. Sapi and her students’ pilot study was supported by Pink Clover, the Colleen Sorbello Breast Cancer Foundation, which was founded by University benefactor Sam Sorbello in honor of his late wife, Colleen. The University’s Colleen Sorbello Research Laboratory in Dodds Hall also bears the name of Colleen, who died of breast cancer.

“Cancer is so heterogenous,” said Dr. Sapi. “If you kill one population, another comes back. This reminds me of bacteria – you may kill most of them, but you have to take an antibiotic for ten days or they will come back. There are so many parallel lines here. I hope this research puts a different perspective on all cancer – not just breast cancer.”

Dr. Sapi’s goal is to identify antibacterial agents that are effective in killing all forms of the bacteria. She found Borrelia can form a protective layer – a biofilm – around themselves, enabling them to resist antibiotics. She and her students also discovered that liquid whole-leaf stevia extract reduced the biofilm mass by about 40 percent, and they continue to explore that as a possible lead.

‘Science can be fun and fascinating’

Dr. Sapi spent five years conducting research with an expert at Columbia University, assisting with a study that focused on a woman from New York who tested positive for Lyme disease and received antibiotic therapy for 16 years. Despite taking many combinations of antibiotics, the woman had serious complications, including seizures, and, ultimately, died from the disease. The researchers sequenced everything in her tissue, finding Borrelia and confirming that the bacteria can form a biofilm, enabling them to resist antibiotics. Dr. Sapi’s research was published in the journal Antibiotics.

In addition to her work on the front lines of Lyme disease and breast cancer research, Dr. Sapi is eager to share her passion for research with her students, and to teach and inspire the researchers of the future.

“I always make sure that students’ projects will get them excited and passionate about science,” she said. “I know they’ll be in the lab for long hours, and I want them to want to be there. As mentors, we need to be encouraging, and we need to show them that science can be fun and fascinating.”

_____________________

**Comment**

We owe a debt of gratitude to Sapi. You would think her work would rock the world, unfortunately, because her research consists of smaller case studies, our public health ‘authorities’ and mainstream medicine sniff at it and just flatly ignore it.  Until they see large randomized controlled trials (RCTs) they aren’t impressed.  This will likely never happen due to lack of funding, abysmal testing, and the wide variability in patients and how they present with differing symptoms.  What little money there is is typically ear-marked with the moniker “Climate change,” which has been proven to be a moot point, yet clung to:  https://madisonarealymesupportgroup.com/2018/11/07/ticks-on-the-move-due-to-migrating-birds-and-photoperiod-not-climate-change/

It’s also interesting to note that other researchers are studying a link between Bartonella (a common coinfection with Lyme) and cancer. 

Regarding the work on stevia – it’s all been done in a test-tube and uses a special formulation which to my knowledge has not been divulged.  I used it with zero effect, but you can read about it here:  https://madisonarealymesupportgroup.com/2015/11/19/stevia-and-bb/

I assure you, it’s not a cure:  https://madisonarealymesupportgroup.com/2017/08/11/stevia-clinical-trial-underway/

Many Lyme doctors; however, use it as a biofilm buster along with other antimicrobials:  https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/

https://madisonarealymesupportgroup.com/2018/03/30/lyme-biofilm-efflux-pumps-dr-christine-green/